Issue link: http://viewer.e-digitaledition.com/i/884976
" Our physicians and clinicians know firsthand the vital role technology plays in developing ways to improve access, lower costs and empower consumers to improve their health. The Smart Health Innovation Lab enables us to share our expertise with entrepreneurs who are equally passionate about enhancing our community's health and well-being." JAN BERGEN, CEO, LANCASTER GENERAL HEALTH Kim Ireland, CEO of the Smart Health Innovation Lab, reviews project development plans with designer Gabriel Kienzle, owner, Reimagine LLC, left, and Corey Meyer, Director of Strategic Acceleration, Lancaster General Health/Penn Medicine. L ANCASTER GENERAL HEALTH ›LG HEALTHœ IS LE VERAGING ITS EX TENSIVE CLINICAL EXPERTISE IN A SMART HEALTH INNOVATION L AB THAT CONVENES HEALTHCARE STAKEHOLDERS TO SPEED DEPLOYMENT OF TECHNOLOGIES THAT DELIVER ON THE QUADRUPLE AIM OF LOWERING COSTS, ENHANCING POPUL ATION HEALTH AND THE PATIENT EXPERIENCE, AND REDUCING PROVIDER BURDEN. OPER ATING WITHIN SILOS is an ine¢- cient approach when it comes to developing medical advances. A partnership among Aspire Ventures, Capital BlueCross, LG Health and Clio Health, the Smart Health Innovation Lab unites a major regional insurer, a nationally recognized health- care system and a venture capital firm to rapidly produce economical, market-ready healthcare technologies. A ONE-OF-A-KIND REGIONAL RESOURCE Slated to open in downtown Lancaster City in late 2017, the roughly 16,000-square-foot space will house simulated care environ- ments, including an outpatient clinic space, an inpatient hospital room, a physical therapy gym, an outpatient pharmacy and a home- care setting to test telemedicine and home monitoring products. Compa nies a nd entrepreneurs pa r- ticipating in the Lab will be able to test their products in real time and in the applicable care setting. Throughout the testing phase, physicians from LG Health will rate the product's clinical viability, while Capital BlueCross experts will determine if the product meets medical necessity require- ments for reimbursement. Technologies that are market-ready, successfully vetted by the physician and payer groups, and compliant with HIPAA and FDA regula- tions will receive certification. The typical certification process is expected to take eight to 12 weeks, says Kim Ireland, Vice President of Healthcare Solutions at Aspire Ventures and CEO of the Smart Health Innovation Lab. "Once companies achieve certification, they will receive alumni status," Ireland says. "Alumni companies will have access to the Lab to host tours and show prospective customers how the technology works in real time. Our intent is that our clinical partners will also embrace these technologies and roll them out throughout their health systems." ENGAGING THE PHYSICIAN COMMUNITY The Smart Health Innovation Lab is cur- rently accepting applications and hopes to partner with 10 companies during its first 12 to 18 months of operation. Physicians who use products that they developed and that are market-ready are also encouraged to apply. "Our goal is to improve patient outcomes and experience, while lowering costs and reducing the burden on physicians as much as possible," Ireland says. "We look forward to working with entrepreneurial physicians with products or services that are market-ready." For information about the Smart Health Innovation Lab, call 717-869-5238 or visit smarthealthinnovationlab.com. ■ LANCASTER GENERAL HEALTH COLLABORATING FOR CARE-ENHANCING, COST-EFFECTIVE INNOVATION BY TIFFANY PARNELL M D N E W S .C O M /// M D N E W S M I D P E N N ■ 2 017 M E D I C A L T E C H N O L O G Y 0 7

